Clinical Trial Update: CLONICEL (Clonidine Sustained Release) as Add-on to Stimulant Medication in 6 to 17 Yr-olds With ADHD [Phase 3]

View source ↗

Summary

This clinical trial update reports completion of a Phase 3 study evaluating CLONICEL (clonidine sustained-release) as an add-on to stimulant therapy in children…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• CLONICEL (clonidine sustained-release)

Snippet

Sponsor: Addrenex Pharmaceuticals, Inc. | Conditions: ADHD | Phase 3 | Status: COMPLETED